GCL
BHVN

Glazer Capital LLC’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Glazer Capital LLC’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,238,525
Closed -$187M – 818
2022
Q3 		$187M Buy
1,238,525
+1,020,837
+469% +$154M 3.43% 1
2022
Q2 		$31.7M Buy
+217,688
New +$31.7M 0.79% 18